Seres Therapeutics, Inc. earnings per share and revenue

MCRB earnings per share for the last quarter are -0.09 USD whereas the estimation was -0.20 USD which accounts for 54.20% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are 0.03 USD, and revenue is expected to reach 16.67 M USD. Also watch annual changes over time to get a bigger picture of MCRB earnings per share and revenue dynamics.